Venture
Capital Rx, Inc.
Latest Form D 2025-09-26- CIK 1782959
- State NY
- Other
- 6 Form D offerings since 2019-07-19
- Total sold
- $500M
- across 6 offerings
- Rounds
- 6
- Form D offerings since 2019-07-19
- Latest round
- $231M
- 2025-09-26 · 021-558942
- Investors
- 8
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-09-26 · $231M
- 2019-07-19$12.4M021-344671
- 2021-01-05$32M021-385278
- 2021-07-14$3.5M021-406267
- 2022-06-13$106M021-448935
- 2024-03-22$115M021-508325
- 2025-09-26$231M021-558942
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($231M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-558942 | First filed2025-09-26 | Latest2025-09-26 | Sought$233M | Sold$231M | Investors8 | Exemptions506(b) |
| 021-508325 | First filed2024-03-22 | Latest2024-03-22 | Sought$312M | Sold$115M | Investors1 | Exemptions506(b) |
| 021-448935 | First filed2022-06-13 | Latest2022-06-13 | Sought$106M | Sold$106M | Investors9 | Exemptions506(b) |
| 021-406267 | First filed2021-07-14 | Latest2021-07-14 | Sought$3.5M | Sold$3.5M | Investors4 | Exemptions506(b) |
| 021-385278 | First filed2021-01-05 | Latest2021-01-05 | Sought$53M | Sold$32M | Investors4 | Exemptions506(b) |
| 021-344671 | First filed2019-07-19 | Latest2019-07-19 | Sought$16.4M | Sold$12.4M | Investors1 | Exemptions506(b) |
Who backs Capital Rx, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-09-26
| Name | Relationship |
|---|---|
| A. J. Loiacono | RelationshipExecutive Officer, Director |
| Ryan Kelly | RelationshipDirector |
| Lenard Marcus | RelationshipDirector |
| Kevin Hill | RelationshipDirector |
| Jared Kesselheim | RelationshipDirector |
| Robert Mittendorff | RelationshipDirector |
| Daniel Delmastro | RelationshipDirector |
| Mark Kandrysawtz | RelationshipDirector |
| Mostafa Kamal | RelationshipDirector |
| Holly Maloney | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other
- State
- New York (NY)
- Exemptions
- Rule 506(b)
- First filed
- 2019-07-19
- Latest filing
- 2025-09-26
Who backs Capital Rx, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗